Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunao Shimizu

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Frontiers in Nutrition|February 11, 2026
Efficacy of 42-month oral administration of glucoraphanin in preventing cognitive decline in individuals at elevated risk of dementia, including those with mild cognitive impairment: a randomized, double-blind, placebo-controlled pilot studySunao Shimizu, Shuya Kasai, Chieko Suzuki, et al.
International Journal of Molecular Sciences|August 12, 2022
Sulforaphane Increase Mitochondrial Biogenesis-Related Gene Expression in the Hippocampus and Suppresses Age-Related Cognitive Decline in MiceSunao Shimizu, Shuya Kasai, Hiromi Yamazaki, et al.
Metabolites|February 25, 2023
Association of Plasma Lipopolysaccharide-Binding Protein Concentration with Dietary Factors, Gut Microbiota, and Health Status in the Japanese General Adult Population: A Cross-Sectional StudyNobuo Fuke, Takahiro Yamashita, Sunao Shimizu, et al.
Plos One|August 12, 2020
Association of single nucleotide polymorphisms in the NRF2 promoter with vascular stiffness with agingSunao Shimizu, Junsei Mimura, Takanori Hasegawa, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Frontiers in Nutrition|February 11, 2026
Efficacy of 42-month oral administration of glucoraphanin in preventing cognitive decline in individuals at elevated risk of dementia, including those with mild cognitive impairment: a randomized, double-blind, placebo-controlled pilot studySunao Shimizu, Shuya Kasai, Chieko Suzuki, et al.
International Journal of Molecular Sciences|August 12, 2022
Sulforaphane Increase Mitochondrial Biogenesis-Related Gene Expression in the Hippocampus and Suppresses Age-Related Cognitive Decline in MiceSunao Shimizu, Shuya Kasai, Hiromi Yamazaki, et al.
Metabolites|February 25, 2023
Association of Plasma Lipopolysaccharide-Binding Protein Concentration with Dietary Factors, Gut Microbiota, and Health Status in the Japanese General Adult Population: A Cross-Sectional StudyNobuo Fuke, Takahiro Yamashita, Sunao Shimizu, et al.
Plos One|August 12, 2020
Association of single nucleotide polymorphisms in the NRF2 promoter with vascular stiffness with agingSunao Shimizu, Junsei Mimura, Takanori Hasegawa, et al.
Pageof 3